Nasopharyngitis and headache were the most common adverse events ( idebenone , eight -LSB- @ % -RSB- and six -LSB- @ % -RSB- of @ patients ; placebo , nine -LSB- @ % -RSB- and seven -LSB- @ % -RSB- of @ patients ) .